Insmed Inc. (NASDAQ: INSM) announced positive results from its ongoing Phase 3 PALM-PAH trial for its…
Tag: clinical trials
Ernexa Therapeutics Stock Rises After Study Validates
Ernexa Therapeutics Inc. shares rose 7.43% to $6.51 following the release of positive results from an…
Veradermics’ Hair Loss Drug Shows Positive Phase 2 Results
Veradermics reported positive results from its Phase 2 study of VDPHL01, an oral treatment for female…